The Senate appears ready to move on a bill that aims to provide greater oversight to large-scale compounders

0

Intravenous news: Medpage Today report “The Senate appears ready to move on a bill that aims to provide greater oversight to large-scale compounders like the one at the center of last fall’s fungal meningitis outbreak. Lawmakers received feedback Thursday on how they can fine-tune a draft bill that creates a new class of compounding pharmacies for those who act more like manufacturers. Stakeholders — including the FDA, a public-policy think tank, and pharmacy groups — were generally supportive of the draft senators released late last month.

“Just from the general tone of what I hear, I think we’re very, very close to having what we need,” Sen. Tom Harkin (D-Iowa), chair of the Senate Health, Education, Labor, and Pensions Committee, said at a hearing on the issue.

Harkin said in his opening statement he hopes to have a bill ready to be considered by the committee before Memorial Day, which is 2 weeks away.”

Main page

Share.

Comments are closed.